Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Radman

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Acta Stomatologica Croatica|January 23, 2019
Knowledge of Oral Cancer among the Fourth and Fifth Year Dental StudentsMaria Radman, Ana Glavina, Ivan Sabol, et al.
Frontiers in Immunology|April 4, 2025
Hexokinase2-engineered T cells display increased anti-tumor functionRaphaëlle Toledano Zur, Shiran Didi Zurinam, Maria Radman, et al.
Cancer Immunology Research|July 22, 2024
Targeting Tumor-Associated Sialic Acids Using Chimeric Switch Receptors Based on Siglec-9 Enhances the Antitumor Efficacy of Engineered T CellsVasyl Eisenberg, Shiran Hoogi, Erel Katzman, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Acta Stomatologica Croatica|January 23, 2019
Knowledge of Oral Cancer among the Fourth and Fifth Year Dental StudentsMaria Radman, Ana Glavina, Ivan Sabol, et al.
Frontiers in Immunology|April 4, 2025
Hexokinase2-engineered T cells display increased anti-tumor functionRaphaëlle Toledano Zur, Shiran Didi Zurinam, Maria Radman, et al.
Cancer Immunology Research|July 22, 2024
Targeting Tumor-Associated Sialic Acids Using Chimeric Switch Receptors Based on Siglec-9 Enhances the Antitumor Efficacy of Engineered T CellsVasyl Eisenberg, Shiran Hoogi, Erel Katzman, et al.
Pageof 1